EMEA-000916-PIP01-10-M07
Key facts
| Invented name |
Lyxumia
|
| Active substance |
lixisenatide
|
| Therapeutic area |
Endocrinology-Gynaecology-Fertility-Metabolism
|
| Decision number |
P/0443/2020
|
| PIP number |
EMEA-000916-PIP01-10-M07
|
| Pharmaceutical form(s) |
Solution for injection in pre-filled pen
|
| Condition(s) / indication(s) |
Treatment of type II diabetes mellitus
|
| Route(s) of administration |
Subcutaneous use
|
| Contact for public enquiries |
Sanofi-Aventis R&D
E-mail: contact-us@sanofi.com |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|